ORAL ANTIVIRAL AGENTS REDUCE THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Singal, Ashwani K. [1 ]
Fontana, Robert J. [2 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1016A / 1016A
页数：1
相关论文
共 50 条
  • [1] Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
    Thiele, Maja
    Gluud, Lise L.
    Dahl, Emilie K.
    Krag, Aleksander
    BMJ OPEN, 2013, 3 (08):
  • [2] TENOFOVIR COMPARED TO ENTECAVIR ON RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Choi, Won-Mook
    Choi, Jonggi
    Lim, Young-Suk
    HEPATOLOGY, 2019, 70 : 307A - 307A
  • [3] Risk prediction models for hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy: A meta-analysis
    Shen, Yueli
    Liu, Jiao
    Han, Zhi
    Jiang, Weiyun
    Cui, Huaizhong
    Xun, Yunhao
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (06)
  • [4] Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis
    Lv, Gui-Ji
    Ji, Dong
    Yu, Lingxiang
    Chen, Hong-Yan
    Chen, Jing
    He, Mengwen
    Wang, Wen-Chang
    Wang, Hong-Bo
    Tsang, Christopher
    Wang, Jianjun
    Yu, Ming-Lung
    Lau, George
    HEPATOLOGY INTERNATIONAL, 2024, 18 (05) : 1459 - 1471
  • [5] Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
    Chang Seok Bang
    Il Han Song
    BMC Gastroenterology, 17
  • [6] Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
    Bang, Chang Seok
    Song, Il Han
    BMC GASTROENTEROLOGY, 2017, 17
  • [7] Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis
    Li, Zhiguo
    Li, Ying
    Li, Xiaoke
    Zhang, Ludan
    Zhao, Nanqi
    Du, Hongbo
    Zhou, Bo
    Ye, Yong'an
    MEDICINE, 2018, 97 (34)
  • [8] Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
    Liu, F.
    Wang, X. -W.
    Chen, L.
    Hu, P.
    Ren, H.
    Hu, H. -D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1253 - 1261
  • [9] Systematic review and meta-analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversion
    Zhou, T. -C.
    Lai, X.
    Feng, M. -H.
    Tang, Y.
    Zhang, L.
    Wei, J.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (10) : 1172 - 1179
  • [10] ASSOCIATION BETWEEN HBsAg LOSS AND RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Choi, Hannah S.
    Anderson, Ryan
    Lenz, Oliver
    Peters, Marion G.
    Janssen, Harry L. A.
    Miller, Veronica
    Hansen, Bettina E.
    HEPATOLOGY, 2019, 70 : 419A - 420A
12345